Active Shortage

APO-NAPROXEN EC TABLETS

APOTEX INC

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of APO-NAPROXEN EC TABLETS in Canada?

Yes. APO-NAPROXEN EC TABLETS 250MG has an active shortage reported to Health Canada (last updated October 16, 2026).

Why is APO-NAPROXEN EC TABLETS not available?

The reason the manufacturer reported: Disruption of the manufacture of the drug.

When will APO-NAPROXEN EC TABLETS be available again?

The manufacturer's estimated resolution date is January 8, 2027. This is an estimate and can change; follow this page to get an email when the status changes.

Can I still get this?Possibly — same-ingredient product records found

StatusActive Shortage

Same-ingredient products on file6 products · 1 same form & route

Expected resolution~3 months remaining (estimate)

Affected strength250MG

Report last updated2026-10-16

Checked by MedShort2026-10-17

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Other Products

PEDIAPHARM NAPROXEN SUSPENSION

MEDEXUS PHARMACEUTICALS INC.

25MG · DIN 02162431

Different strengthDifferent dosage formSame routeNo current shortage

Compare these two →

NAPROXEN-NA DF

PRO DOC LIMITEE

550MG · DIN 02153386

Different strengthDifferent dosage formSame routeNo current shortage

Compare these two →

NAPROXEN-NA

PRO DOC LIMITEE

275MG · DIN 00887056

Different strengthDifferent dosage formSame routeNo current shortage

Compare these two →

ANAPROX DS

SEARCHLIGHT PHARMA INC

550MG · DIN 02162717

Different strengthDifferent dosage formSame routeNo current shortage

Compare these two →

TEVA-NAPROXEN EC

TEVA CANADA LIMITED

500MG · DIN 02243314

Different strengthSame dosage formSame routeNo current shortage

Compare these two →

ALEVE BACK AND BODY PAIN

BAYER INC

220MG · DIN 02436337

Different strengthDifferent dosage formSame routeNo current shortage

Compare these two →

What this means

Does this mean my pharmacy is out of stock?

Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.

What should I do?

Contact your pharmacy before your current supply runs low, and ask your pharmacist about next steps if they're out.

Estimated Resolution

2027-01-08

~3 months remaining (estimate)

This is the manufacturer's estimated date, not a guarantee — actual resolution may come earlier or later.

DIN

02246699

Strength

250MG

Dosage Form

TABLET (ENTERIC-COATED)

Route

ORAL

Active Ingredient

NAPROXEN

Tier

Unrated

Last Updated

2026-10-16

Reason for Shortage

Disruption of the manufacture of the drug.

Source

View original report on healthproductshortages.ca ↗

Past Reports for This Drug

APO-NAPROXEN EC TABLETS has 2 shortage/discontinuation reports on file — this is one of them.

2026-09-25

Resolved

Disruption of the manufacture of the drug.

Other Products from APOTEX INC

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

24HR NASAL ALLERGY RELIEF

50MCG · DIN 02460513

ACETAMINOPHEN CAPLETS 325 MG

325MG · DIN 02362341

ACETAMINOPHEN CAPLETS 500 MG

500MG · DIN 02362368

ACETAMINOPHEN HEADACHE ULTRA RELIEF

DIN 02290901

ACETAMINOPHEN TABLETS USP 325 MG

325MG · DIN 02362422

ACETAMINOPHEN TABLETS USP 500 MG

500MG · DIN 02362244